Maintaining brain health by monitoring inflammatory processes: A mechanism to promote successful aging

Aging and Disease

Volumn 3, Issue 1, 2012, Pages 16-33

  Rosano, Caterina ^a   Marsland, Anna L ^b   Gianaros, Peter J ^b  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; Brain health; Central inflammatory processes

Indexed keywords

EID: 84868130413     PISSN: None     EISSN: 21525250     Source Type: Journal    
DOI: None     Document Type: Review

References (199)

1. Depp CA and Jeste DV (2006). Definitions and predictors of successful aging: a comprehensive review of larger quantitative studies. Am J Geriatr Psychiatry, 14: 6-20
2. Rosano C, Newman AB, Katz R, Hirsch CH and Kuller LH (2008). Association between lower digit symbol substitution test score and slower gait and greater risk of mortality and of developing incident disability in well-functioning older adults. J Am Geriatr Soc, 56: 1618-1625
3. Gorelick PB (2010). Role of inflammation in cognitive impairment: results of observational epidemiological studies and clinical trials. Ann N Y Acad Sci, 1207: 155-162
4. Kiecolt-Glaser JK, Preacher KJ, MacCallum RC, Atkinson C, Malarkey WB and Glaser R (2003). Chronic stress and age-related increases in the proinflammatory cytokine IL-6. Proc Natl Acad Sci U S A, 100: 9090-9095
5. Krabbe KS, Pedersen M and Bruunsgaard H (2004). Inflammatory mediators in the elderly. Exp Gerontol, 39: 687-699
6. Rao KM, Pieper CS, Currie MS and Cohen HJ (1994). Variability of plasma IL-6 and crosslinked fibrin dimers over time in community dwelling elderly subjects. Am J Clin Pathol, 102: 802-805
7. Ferrucci L, Harris TB, Guralnik JM, Tracy RP, Corti MC, Cohen HJ, Penninx B, Pahor M, Wallace R and Havlik RJ (1999). Serum IL-6 level and the development of disability in older persons. J Am Geriatr Soc, 47: 639-646
8. Luc G, Bard JM, Juhan-Vague I, Ferrieres J, Evans A, Amouyel P, Arveiler D, Fruchart JC and Ducimetiere P (2003). C-reactive protein, interleukin-6, and fibrinogen as predictors of coronary heart disease: the PRIME Study. Arterioscler Thromb Vasc Biol, 23: 1255-1261
9. Pradhan AD, Manson JE, Rifai N, Buring JE and Ridker PM (2001). C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA, 286: 327-334
10. Ridker PM, Hennekens CH, Buring JE and Rifai N (2000). C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med, 342: 836-843
11. Buchanan JB, Sparkman NL, Chen J and Johnson RW (2008). Cognitive and neuroinflammatory consequences of mild repeated stress are exacerbated in aged mice. Psychoneuroendocrinology, 33: 755-765
12. Chen J, Buchanan JB, Sparkman NL, Godbout JP, Freund GG and Johnson RW (2008). Neuroinflammation and disruption in working memory in aged mice after acute stimulation of the peripheral innate immune system. Brain Behav Immun, 22: 301-311
13. Mohamed-Ali V, Goodrick S, Rawesh A, Katz DR, Miles JM, Yudkin JS, Klein S and Coppack SW (1997). Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab, 82: 4196-4200
14. Papanicolaou DA, Wilder RL, Manolagas SC and Chrousos GP (1998). The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med, 128: 127-137
15. Perry VH (2004). The influence of systemic inflammation on inflammation in the brain: implications for chronic neurodegenerative disease. Brain Behav Immun, 18: 407-413
16. Perry VH (2010). Contribution of systemic inflammation to chronic neurodegeneration. Acta Neuropathol, 120: 277-286
17. Sparkman NL and Johnson RW (2008). Neuroinflammation associated with aging sensitizes the brain to the effects of infection or stress. Neuroimmunomodulation, 15: 323-330
18. Spooren A, Kolmus K, Laureys G, Clinckers R, De Keyser J, Haegeman G, Gerlo S. (2011). Interleukin-6, a mental cytokine. Brain Res Rev, Epub ahead of print
19. Libby P, Ridker PM and Maseri A (2002). Inflammation and atherosclerosis. Circulation, 105: 1135-1143
20. Carty M, Bowie, A. G. (2011). Evaluating the role of Toll-like receptors in diseases of the central nervous system. Biochem Pharmacol, 81: 825-837
21. Godbout JP and Johnson RW (2004). Interleukin-6 in the aging brain. J Neuroimmunol, 147: 141-144
22. Sarkar D and Fisher PB (2006). Molecular mechanisms of aging-associated inflammation. Cancer Lett, 236: 13-23
23. McGeer PL and McGeer EG (2004). Inflammation and the degenerative diseases of aging. Ann N Y Acad Sci, 1035: 104-116
24. Marsland AL (2011). Inflammation. Neuropsychology of Cardiovascular Disease, 2nd Edition, Shari R Waldstein (Editor), Merrill F Elias (Editor), in press
25. Salthouse TA (2004). What and when of cognitive aging.. Current Directions in Psychological Science, 13
26. Buckner RL (2004). Memory and executive function in aging and AD: multiple factors that cause decline and reserve factors that compensate.. Neuron, 44
27. Hedden T, Gabrieli, J. D. (2004). Insights into the ageing mind: a view from cognitive neuroscience.. Nature Reviews Neuroscience, 5
28. Davis HP, Small, S. A., Stern, Y., Mayeux, R., Feldstein, S. N., & Keller, F. R. (2003). Acquisition, recall, and forgetting of verbal information in long-term memory by young, middle-aged, and elderly individuals.. Cortex, 39
29. Huh TJ, Kramer, J. H., Gazzaley, A., & Delis, D. C. (2006). Response bias and aging on a recognition memory task Journal of the International Neuropsychological Society, 12 1-7
30. Wecker NS, Kramer, J. H., Hallam, B. J., & Delis, D. C. (2005). Mental flexibility: age effects on switching. Neuropsychology, 19
31. Fjell AM, Walhovd KB. (2010). Structural brain changes in aging: courses, causes and cognitive consequences. Rev Neurosci, 21: 187-221
32. O'Sullivan M (2010). Imaging small vessel disease: lesion topography, networks, and cognitive deficits investigated with MRI. Stroke, 41: S154-158
33. Laakso MP, Partanen K, Riekkinen P, Lehtovirta M, Helkala EL, Hallikainen M, Hanninen T, Vainio P, Soininen H. (1996). Hippocampal volumes in Alzheimer's disease, Parkinson's disease with and without dementia, and in vascular dementia: An MRI study. Neurology, 46: 678-681
34. De Leon MJ, Convit A, de Santi S, Bobinski M. (1999). Structural neuroimaging: Eearly diagnosis and staging of Alzheimer's disease.. Alzheimer's Disease and Related Disorders, 14: 105-126
35. Schelten P, Fox N, Barkhof F, De Carli C. (2002). Structural magnetic resonance imaging in the practical assessment of dementia: beyond exclusion. Lancet Neurol, 1: 13-21
36. van Dijk EJ, Prins ND, Vermeer SE, Vrooman HA, Hofman A, Koudstaal PJ and Breteler MM (2005). C-reactive protein and cerebral small-vessel disease: the Rotterdam Scan Study. Circulation, 112: 900-905
37. Jefferson AL, Massaro JM, Wolf PA, Seshadri S, Au R, Vasan RS, Larson MG, Meigs JB, Keaney JF, Jr., Lipinska I, Kathiresan S, Benjamin EJ and DeCarli C (2007). Inflammatory biomarkers are associated with total brain volume: the Framingham Heart Study. Neurology, 68: 1032-1038
38. Hoshi T, Kitagawa K, Yamagami H, Furukado S, Hougaku H and Hori M (2005). Relations of serum high-sensitivity C-reactive protein and interleukin-6 levels with silent brain infarction. Stroke, 36: 768-772
39. Wright CB, Moon Y, Paik MC, Brown TR, Rabbani L, Yoshita M, DeCarli C, Sacco R and Elkind MS (2009). Inflammatory biomarkers of vascular risk as correlates of leukoariosis. Stroke, 40: 3466-3471
40. Wada M, Nagasawa H, Kurita K, Koyama S, Arawaka S, Kawanami T, Tajima K, Daimon M and Kato T (2008). Cerebral small vessel disease and C-reactive protein: results of a cross-sectional study in community-based Japanese elderly. J Neurol Sci, 264: 43-49
41. Fornage M, Chiang YA, O'Meara ES, Psaty BM, Reiner AP, Siscovick DS, Tracy RP and Longstreth WT, Jr. (2008). Biomarkers of Inflammation and MRI-Defined Small Vessel Disease of the Brain: The Cardiovascular Health Study. Stroke, 39: 1952-1959
42. Yoshida M, Higashi K, Kobayashi E, Saeki N, Wakui K, Kusaka T, Takizawa H, Kashiwado K, Suzuki N, Fukuda K, Nakamura T, Watanabe S, Tada K, Machi Y, Mizoi M, Toida T, Kanzaki T, Tomitori H, Kashiwagi K and Igarashi K (2010). Correlation between images of silent brain infarction, carotid atherosclerosis and white matter hyperintensity, and plasma levels of acrolein, IL-6 and CRP. Atherosclerosis, 211: 475-479
43. Baune BT, Ponath G, Rothermundt M, Roesler A and Berger K (2009). Association between cytokines and cerebral MRI changes in the aging brain. J Geriatr Psychiatry Neurol, 22: 23-34
44. Kuo HK and Lipsitz LA (2004). Cerebral white matter changes and geriatric syndromes: is there a link? J Gerontol A Biol Sci Med Sci, 59: 818-826
45. Awad IA, P. C. Johnson, R. F. Spetzler, J. A. Hodak. (1986). Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. II. Postmortem pathological correlations.. Stroke, 17: 1090-1097
46. Fazekas F, R. Schmidt and P. Scheltens (1998). Pathophysiologic mechanisms in the development of age-related white matter changes of the brain. Dement Geriatr Cogn. Disord, Suppl 1: 2-5
47. Marshall VG, W. G. Bradley Jr., C. E. Marshall, T. Bhoopat and R. H. Rhodes. (1988). Deep white matter infarction: correlation of MR imaging and histopathologic findings. Radiology, 167: 517-522
48. Pantoni LaJHG (1997). Pathogenesis of leukoaraiosis: a review Stroke, 28: 652-659
49. Peters A (2002). The effects of normal aging on myelin and nerve fibers: A review. J. Neurocytology, 31: 581-593
50. Raz NHoAaC (2000). Aging of the brain and its impact on cognitive performance: Integration of structural and functional findings. Handbook of Aging and Cognition In F. I. M. Craik and T. A. Salthouse (eds.), Erlbaum. Mahwah, NJ: 1-90
51. Becker JA, Hedden T, Carmasin J, Maye J, Rentz DM, Putcha D, Fischl B, Greve DN, Marshall GA, Salloway S, Marks D, Buckner RL, Sperling RA, Johnson KA. (2010). Amyloid-β associated cortical thinning in clinically normal elderly. Ann Neurol, Epub ahead of print
52. Oh H, Mormino EC, Madison C, Hayenga A, Smiljic A, Jagust WJ. (2011). β-Amyloid affects frontal and posterior brain networks in normal aging. Neuroimage, 54: 1887-1895
53. Kotur-Stevuljevic J, Memon L, Stefanovic A, Spasic S, Spasojevic-Kalimanovska V, Bogavac-Stanojevic N, Kalimanovska-Ostric D, Jelic-Ivanovic Z and Zunic G (2007). Correlation of oxidative stress parameters and inflammatory markers in coronary artery disease patients. Clin Biochem, 40: 181-187
54. Rovaris M, Iannucci G, Cercignani M, Sormani MP, De Stefano N, Gerevini S, Comi G and Filippi M (2003). Age-related changes in conventional, magnetization transfer, and diffusion-tensor MR imaging findings: study with whole-brain tissue histogram analysis. Radiology, 227: 731-738
55. Benedetti B, Charil, A.,Rovaris, M., Judica, E., Valsasina, P., Sormani, M.P., Filippi, M. (2006). Influence of aging on brain gray and white matter changes assessed by conventional, MT, and DT MRI. Neurology, 66: 535-539
56. Venkatraman V, Aizenstein HJ, Newman AB, Yaffe K, Harris T, Kritchevski S, Hayonayon,HN, Rosano C. (2011). Maintaining cognition in old age is associated with cingulate cortex microstructure.. Frontiers in Neuroscience, In Press
57. Kenne E and Lindbom L (2010). Imaging inflammatory plasma leakage in vivo. Thromb Haemost, 105: 783-789
58. Sibson NR, Anthony DC, van Kasteren S, Dickens A, Perez-Balderas F, McAteer MA, Choudhury RP and Davis BG (2011). Molecular MRI approaches to the detection of CNS inflammation. Methods Mol Biol, 711: 379-396
59. Sibson NR, Blamire AM, Bernades-Silva M, Laurent S, Boutry S, Muller RN, Styles P and Anthony DC (2004). MRI detection of early endothelial activation in brain inflammation. Magn Reson Med, 51: 248-252
60. McAteer MA, von Zur Muhlen C, Anthony DC, Sibson NR and Choudhury RP (2011). Magnetic resonance imaging of brain inflammation using microparticles of iron oxide. Methods Mol Biol, 680: 103-115
61. Jin A, Tuor UI, Rushforth D, Filfil R, Kaur J, Ni F, Tomanek B, Barber PA. (2009). Magnetic resonance molecular imaging of post-stroke neuroinflammation with a P-selectin targeted iron oxide nanoparticle. Contrast Media Mol Imaging, 4: 305-311
62. Butler T, Ichise M, Teich AF, Gerard E, Osborne J, French J, Devinsky O, Kuzniecky R, Gilliam F, Pervez F, Provenzano F, Goldsmith S, Vallabhajosula S, Stern E and Silbersweig D (2011). Imaging Inflammation in a Patient with Epilepsy Due to Focal Cortical Dysplasia. J Neuroimaging
63. Cagnin A, Brooks DJ, Kennedy AM, Gunn RN, Myers R, Turkheimer FE, Jones T and Banati RB (2001). In-vivo measurement of activated microglia in dementia. Lancet, 358: 461-467
64. Christoforidis GA, Yang M, Kontzialis MS, Larson DG, Abduljalil A, Basso M, Yang W, Ray-Chaudhury A, Heverhagen J, Knopp MV and Barth RF (2009). High resolution ultra high field magnetic resonance imaging of glioma microvascularity and hypoxia using ultra-small particles of iron oxide. Invest Radiol, 44: 375-383
65. Rohani R, de Chickera SN, Willert C, Chen Y, Dekaban GA and Foster PJ (2010). In Vivo Cellular MRI of Dendritic Cell Migration Using Micrometer-Sized Iron Oxide (MPIO) Particles. Mol Imaging Biol
66. Tysiak E, Asbach P, Aktas O, Waiczies H, Smyth M, Schnorr J, Taupitz M and Wuerfel J (2009). Beyond blood brain barrier breakdown - in vivo detection of occult neuroinflammatory foci by magnetic nanoparticles in high field MRI. J Neuroinflammation, 6: 20
67. Versijpt J, Debruyne JC, Van Laere KJ, De Vos F, Keppens J, Strijckmans K, Achten E, Slegers G, Dierckx RA, Korf J and De Reuck JL (2005). Microglial imaging with positron emission tomography and atrophy measurements with magnetic resonance imaging in multiple sclerosis: a correlative study. Mult Scler, 11: 127-134
68. Saleh A, Schroeter M, Jonkmanns C, Hartung HP, Modder U and Jander S (2004). In vivo MRI of brain inflammation in human ischaemic stroke. Brain, 127: 1670-1677
69. Tang TY, Howarth SP, Miller SR, Graves MJ, Patterson AJ, JM UK-I, Li ZY, Walsh SR, Brown AP, Kirkpatrick PJ, Warburton EA, Hayes PD, Varty K, Boyle JR, Gaunt ME, Zalewski A and Gillard JH (2009). The ATHEROMA (Atorvastatin Therapy: Effects on Reduction of Macrophage Activity) Study. Evaluation using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging in carotid disease. J Am Coll Cardiol, 53: 2039-2050
70. Pantoni L, Garcia JH (1997). Pathogenesis of leukoaraiosis: a review. Stroke, 28: 652-659
71. de la Torre JC (2000). Impaired cerebromicrovascular perfusion. Summary of evidence in support of its causality in Alzheimer's disease. Ann N Y Acad Sci, 924: 136-152
72. Wu M, Rosano C, Butters M, Whyte E, Nable M, Crooks R, Meltzer CC, Reynolds CF, 3rd and Aizenstein HJ (2006). A fully automated method for quantifying and localizing white matter hyperintensities on MR images. Psychiatry Res, 148: 133-142
73. Bhat NR (2010). Linking cardiometabolic disorders to sporadic Alzheimer's disease: a perspective on potential mechanisms and mediators. J Neurochem., 115: 551-562
74. den Heijer T, Launer LJ, Prins ND, van Dijk EJ, Vermeer SE, Hofman A, Koudstaal PJ and Breteler MM (2005). Association between blood pressure, white matter lesions, and atrophy of the medial temporal lobe. Neurology, 64: 263-267
75. Dufouil C, Chalmers J, Coskun O, Besançon V, Bousser M, Guillon P, MacMahon S, Mazoyer B, Neal B, Woodward M, Tzourio-Mazoyer N and Tzourio C (2005). Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy. Circulation, 112: 1644-1650
76. Dufouil C, de Kersaint-Gilly A, Besancon V, Levy C, Auffray E, Brunnereau L, Alperovitch A and Tzourio C (2001). Longitudinal study of blood pressure and white matter hyperintensities: the EVA MRI Cohort. Neurology, 56: 921-926
77. Wiseman RM, Saxby BK, Burton EJ, Barber R, Ford GA and O'Brien JT (2004). Hippocampal atrophy, whole brain volume, and white matter lesions in older hypertensive subjects. Neurology, 63: 1892-1897
78. Momijan-mayor IaJCB (2005). The pathophysiology of watershed infarction in internal carotid artery disease: review of cerebral perfusion studies. Stroke, 36: 567-577
79. Vasilevko V, Passos GF, Quiring D, Head E, Kim RC, Fisher M, Cribbs DH. (2010). Aging and cerebrovascular dysfunction: contribution of hypertension, cerebral amyloid angiopathy, and immunotherapy. Ann N Y Acad Sci [1207:] 58-70
80. Lee AY, Jeong SH, Choi BH, Sohn EH, Chui H. (2006). Pulse pressure correlates with leukoaraiosis in Alzheimer disease. Arch Gerontol Geriatr, 42: 157-166
81. Jongen C and Biessels GJ (2008). Structural brain imaging in diabetes: a methodological perspective. European journal of pharmacology, 585: 208-218
82. van Harten B, Oosterman JM, Potter van Loon BJ, Scheltens P and Weinstein HC (2007). Brain lesions on MRI in elderly patients with type 2 diabetes mellitus. European neurology, 57: 70-74
83. Brands AM, Biessels GJ, Kappelle LJ, de Haan EH, de Valk HW, Algra A and Kessels RP (2007). Cognitive functioning and brain MRI in patients with type 1 and type 2 diabetes mellitus: a comparative study. Dementia and geriatric cognitive disorders, 23: 343-350
84. McEwen BS and Gianaros PJ (2011). Stress- and allostasis-induced brain plasticity. Annu Rev Med, 62: 431-445
85. Hertzog C, Kramer A F Wilson R S & Lindenberger U (2009). Enrichment Effects on Adult Cognitive Development: Can the Functional Capacity of Older Adults Be Preserved and Enhanced?. Psychological Science in the Public Interest, 9 1-65
86. Bermudez EA, Rifai, N., Buring, J., Manson, J. E., & Ridker, P. M. (2002). Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women.. Arteriosclerosis, Thrombosis & Vascular Biology, 22 1668-1673
87. Cournot M, Marquié, J. C., Ansiau, D., Martinaud, C., Fonds, H., Ferrières, J., & Ruidavets, J. B. (2006). Relation between body mass index and cognitive function in healthy middle-aged men and women. Neurology, 67 1208-1214
88. Gunstad J, Paul, R. H., Cohen, R. A., Tate, D. F., & Gordon, E. (2006). Obesity is associated with memory deficits in young and middle-aged adults.. Eating & Weight Disorders, 11: e15-19
89. Gustafson D, Rothenberg, E., Blennow, K., Steen, B., & Skoog, I. (2003). An 18-year follow-up of overweight and risk of Alzheimer disease Archives of Internal Medicine, 163: 1524-1528
90. Gustafson D, Lissner, L., Bengtsson, C., Bjorkelund, C., & Skoog. I. (2004). A 24-year follow-up of body mass index and cerebral atrophy.. Neurology, 63 1876-1881
91. Deary IJ, Bastin ME, Pattie A, Clayden JD, Whalley LJ, Starr JM and Wardlaw JM (2006). White matter integrity and cognition in childhood and old age. Neurology, 66: 505-512
92. Oberheiden T, Blahak C, Nguyen XD, Fatar M, Elmas E, Morper N, Dempfle CE, Bazner H, Hennerici M, Borggrefe M and Kalsch T Activation of platelets and cellular coagulation in cerebral small-vessel disease. Blood Coagul Fibrinolysis, 21: 729-735
93. Gerges NZ, Aleisa, A. M., & Alkadhi, K. A. (2003). Impaired long-term potentiation in obese zucker rats: possible involvement of presynaptic mechanism. Neuroscience, 120
94. Khaodhiar L, Ling, P.R., Blackburn, G. L., & Bistrian, B. R. (2004). Serum levels of interleukin-6 and C-reactive protein correlate with body mass index across the broad range of obesity.. Journal of Parenteral & Enteral Nutrition, 28: 410-415
95. Marsland AL, Petersen K L Sathanoori R Muldoon M F Neumann S A Ryan C et al (2006). Interleukin-6 covaries inversely with cognitive performance among middle-aged community volunteers Psychosom Med, 68: 895-903
96. Marsland AL, Gianaros PJ, Abramowitch SM, Manuck SB and Hariri AR (2008). Interleukin-6 covaries inversely with hippocampal grey matter volume in middle-aged adults. Biol Psychiatry, 64: 484-490
97. Drake C, Boutin, H.,Jones, M. S., Denes, A., McColl BW, Selvarajah JR, Hulme S, Georgiou RF, Hinz R, Gerhard A, Vail A, Prenant C, Julyan P, Maroy R, Brown G, Smigova A, Herholz K, Kassiou M, Crossman D, Francis S, Proctor SD, Russell JC, Hopkins SJ, Tyrrell PJ, Rothwell NJ and Allan SM (2011). Brain inflammation is induced by co-morbidities and risk factors for stroke. Brain Behav Immun
98. Bassuk SS, Glass, T. A., & Berkman, L. F. (1999). Social disengagement and incident cognitive decline in community-dwelling elderly persons.. Ann Intern Med, 131: 165-173
99. Barnes LL, Mendes de Leon, C. F., Wilson, R. S., Bienias, J. L., & Evans, D. A. (2004). Social resources and cognitive decline in a population of older African Americans and whites.. Neurology, 63(2322-2326
100. Lovden M, Ghisletta P & Lindenberger U (2005). Social participation attenuates decline in perceptual speed in old and very old age Psychol Aging, 20: 423-434
101. Zunzunegui MV, Alvarado B E Del Ser T & Otero A (2003). Social networks social integration and social engagement determine cognitive decline in community-dwelling Spanish older adults J Gerontol B Psychol Sci Soc Sci, 58 S93-S100
102. Ertel KA, Glymour M M & Berkman L F (2008). Effects of social integration on preserving memory function in a nationally representative US elderly population Am J Public Health, 98 1215-1220
103. Kramer AF, Erickson KI and Colcombe SJ (2006). Exercise, cognition, and the aging brain. J Appl Physiol, 101: 1237-1242
104. Kramer AF, Hahn S, Cohen NJ, Banich MTM, E., Harrison CR, Chason J, Vakil E, Bardell L, Boileau R and Colcombe A (1999). Ageing, fitness and neurocognitive function. Nature, 400: 418-419
105. Weiss N, Miller F, Cazaubon S and Couraud PO (2009). The blood-brain barrier in brain homeostasis and neurological diseases. Biochim Biophys Acta, 1788: 842-857
106. Waldstein SR, P. P. Giggey, J. F. Thayer and A. B. Zonderman. (2005). Nonlinear relations of blood pressure to cognitive function: the Baltimore Longitudinal Study of Aging.. Hypertension, 45: 374-379
107. Forette F, M. L. Seux, J. A. Staessen, L. Thijs, W. H. Birkenhager, M. R. Babarskiene, S. Babeanu, A. Bossini, (1998). Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet., 52: 1347-1351
108. Applegate WB, S. Pressel, J. Wittes, J. Luhr, R. B. Shekelle, G. H. Camel, M. R. Greenlick, E. Hadley, L. Moye, H. M. Perry Jr. (1994). Impact of the treatment of isolated systolic hypertension on behavioral variables. Arch. Intern. Med., 154: 2154-2160
109. Park DC and Reuter-Lorenz P (2009). The adaptive brain: aging and neurocognitive scaffolding. Annual review of psychology, 60: 173-196
110. Rosano C, V.K. Venkatraman, J. Guralnik, A.B.Newman, N.W. Glynn, L.Launer, C.A.Taylor, J.Williamson, S.Studenski, M.Pahor, H.J. Aizenstein (2010). Psychomotor speed and functional brain MRI 2 years after completing a physical activity treatment. J Gerontol A Biol Sci Med Sci, 65: 639-647
111. Erickson KI, Prakash RS, Voss MW, Chaddock L, Hu L, Morris KS, White SM, Wojcicki TR, McAuley E and Kramer AF (2009). Aerobic fitness is associated with hippocampal volume in elderly humans. Hippocampus, 19: 1030-1039
112. De Leeuw FE, J. C. De Groot, M. Oudkerk, J. C. Witteman, A. Hofman, J. Van Gijn and M. M. Breteler. (2002). Hypertension and cerebral white matter lesions in a prospective cohort study.. Brain, 125: 765-772
113. Heinecke J (1999) Sources of vascular axidative stress., Kluwer Academic Publishers, Boston
114. Chung HY, Sung B, Jung KJ, Zou Y and Yu BP (2006). The molecular inflammatory process in aging. Antioxid Redox Signal, 8: 572-581
115. Kotur-Stevuljevic J, Memon L, Stefanovic A, Spasic S, Spasojevic-Kalimanovska V, Bogavac-Stanojevic N, Kalimanovska-Ostric D, Jelic-Ivanovic Z and Zunic G (2007). Correlation of oxidative stress parameters and inflammatory markers in coronary artery disease patients. Clinical Biochemistry, 40: 181-187
116. Dohi Y, Takase H, Sato K and Ueda R (2007). Association among C-reactive protein, oxidative stress, and traditional risk factors in healthy Japanese subjects. Int J Cardiol, 115: 63-66
117. Abramson JL, Hooper WC, Jones DP, Ashfaq S, Rhodes SD, Weintraub WS, Harrison DG, Quyyumi AA and Vaccarino V (2005). Association between novel oxidative stress markers and C-reactive protein among adults without clinical coronary heart disease. Atherosclerosis, 178: 115-121
118. Meda L, Cassatella MA, Szendrei GI, Otvos L Jr, Baron P, Villalba M, Ferrari D, Rossi F. (1995). Activation of microglial cells by beta-amyloid protein and interferon-gamma. Nature, 374: 647-650
119. Rogers J, Strohmeyer R, Kovelowski CJ, Li R. (2002). Microglia and inflammatory mechanisms in the clearance of amyloid beta peptide. Glia, 40: 260-269
120. Barrientos RM, Sprunger, D. B., Campeau, S., Higgins, E. A., Watkins, L. R., Rudy, J. W., et al. (2003). Brain-derived neurotrophic factor mRNA downregulation produced by social isolation is blocked by intrahippocampal interleukin-1 receptor antagonist.. Neuroscience, 121: 847-853.
121. Minghetti L (2005). Role of inflammation in neurodegenerative diseases. Curr Opin Neurol, 18: 315-321
122. Banks WA (2005). Blood-brain barrier transport of cytokines: a mechanism for neuropathology. Curr Pharm Des, 11: 973-984
123. Banks WA, Erickson, M. A. (2010). The blood-brain barrier and immune function and dysfunction. Neurobiol Dis, 37: 26-32
124. Banks WA, Farr SA and Morley JE (2002). Entry of blood-borne cytokines into the central nervous system: effects on cognitive processes. Neuroimmuno-modulation, 10: 319-327
125. Stamatovic SM, Keep RF and Andjelkovic AV (2008). Brain endothelial cell-cell junctions: how to open the blood brain barrier. Curr Neuropharmacol, 6: 179-192
126. Dilger RN and Johnson RW (2008). Aging, microglial cell priming, and the discordant central inflammatory response to signals from the peripheral immune system. J Leukoc Biol, 84: 932-939
127. Black PH and Garbutt LD (2002). Stress, inflammation, and cardiovascular disease. J Psychosom Res, 52: 1-23
128. Gadient RA, & Otten, U. (1994). Expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) mRNAs in rat brain during postnatal development.. Brain Research, 637 10-14
129. Schobitz B, De Kloet, E. R., & Holsboer, F. (1994). Gene expression and function of interleukin 1, interleukin 6 and tumor necrosis factor in the brain.. Progress in Neurobiology, 44 397-432
130. Vitkovic L, Konsman, J. P., Bockaert, J., Dantzer, R., Homburger, V., & Jacque, C. (2000). Cytokine signals propagate through the brain.. Molecular Psychiatry, 5: 604-615
131. Van Wagoner NJ and Benveniste EN (1999). Interleukin-6 expression and regulation in astrocytes. J Neuroimmunol, 100: 124-139
132. Gradient R, Otten U. (1994). Expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) mRNAs in rat brain during postnatal development. Brain Research, 637
133. McAfoose J and Baune BT (2009). Evidence for a cytokine model of cognitive function. Neurosci Biobehav Rev, 33: 355-366
134. Vallieres L, Campbell IL, Gage FH and Sawchenko PE (2002). Reduced hippocampal neurogenesis in adult transgenic mice with chronic astrocytic production of interleukin-6. J Neurosci, 22: 486-492
135. Montaner J, Rovira A, Molina CA, Arenillas JF, Ribo M, Chacon P, Monasterio J and Alvarez-Sabin J (2003). Plasmatic level of neuroinflammatory markers predict the extent of diffusion-weighted image lesions in hyperacute stroke. J Cereb Blood Flow Metab, 23: 1403-1407
136. Takano T, Ohno M, Takeuchi Y, Mandai R and Yoshida S (2002). Cytotoxic edema and interleukin-6 in hypertensive encephalopathy. Pediatr Neurol, 26: 71-73
137. Tong Y, Wang Z, Geng Y, Liu J, Zhang R, Lin Q, Li X, Huang D, Gao S, Hu D, Li Y, Cheng J and Lu Z (2010). The association of functional polymorphisms of IL-6 gene promoter with ischemic stroke: analysis in two Chinese populations. Biochem Biophys Res Commun, 391: 481-485
138. Ishikawa J, Tamura Y, Hoshide S, Eguchi K, Ishikawa S, Shimada K and Kario K (2007). Low-grade inflammation is a risk factor for clinical stroke events in addition to silent cerebral infarcts in Japanese older hypertensives: the Jichi Medical School ABPM Study, wave 1. Stroke, 38: 911-917
139. Nakase T, Yamazaki T, Ogura N, Suzuki A and Nagata K (2008). The impact of inflammation on the pathogenesis and prognosis of ischemic stroke. J Neurol Sci, 271: 104-109
140. Waje-Andreassen U, Krakenes J, Ulvestad E, Thomassen L, Myhr KM, Aarseth J and Vedeler CA (2005). IL-6: an early marker for outcome in acute ischemic stroke. Acta Neurol Scand, 111: 360-365
141. Kuriyama N, Mizuno T, Kita M, Nagakane Y, Hosomi A, Harada S, Takeda K, Ozasa K, Yamada K, Tokuda T, Watanabe Y and Nakagawa M (2009). Predictive markers of blood cytokine and chemokine in recurrent brain infarction. J Interferon Cytokine Res, 29: 729-734
142. Weaver JD, Huang, M. H., Albert, M., Harris, T., Rowe, J. W., & Seeman, T. E (2002). Interleukin-6 and risk of cognitive decline: MacArthur Studies of Successful Aging.. Neurology, 59: 371-378
143. Holmes C, Cunningham, C., Zotova, E., Woolford, J., Dean, C., Kerr, S., Culliford, D., & Perry, V. H. (2009). Systemic inflammation and disease progression in Alzheimer disease. Neurology, 73: 768-774
144. Yasojima K, Schwab C, McGeer EG and McGeer PL (2000). Human neurons generate C-reactive protein and amyloid P: upregulation in Alzheimer's disease. Brain Res, 887: 80-89
145. Yaffe K, Lindquist, K., Penninx, B. W., Simonsick, E. M., Pahor, M., Kritchevsky, S., Launer, L., Kuller, L., Rubin, S., & Harris, T. (2003). Inflammatory markers and cognition in well-functioning African-American and white elders. Neurology, 61 76-80
146. D'Mello C, Le T, Swain MG (2009). Cerebral microglia recruit monocytes into the brain in response to tumor necrosis factor α signaling during peripheral organ inflammation. J Neurosci Res, 29: 2089-2102
147. Emmer BJ, van der Bijl AE, Huizinga TW, Breedveld FC, Steens SC, Th Bosma GP, van Buchem MA and van der Grond J (2009). Brain involvement in rheumatoid arthritis: a magnetic resonance spectroscopy study. Arthritis Rheum, 60: 3190-3195
148. Mangiafico RA, Sarnataro F, Mangiafico M, Fiore CE. (2006). Impaired cognitive performance in asymptomatic peripheral arterial disease: relation to C-reactive protein and D-dimer levels. Age Ageing, 35
149. Baysal T, Ozisik HI, Karlidag R, Sarac K, Baysal O, Dusak A, et al. (2003). Proton MRS in Behçet's disease with and without neurological findings.. Neuroradiology, 45 860-864
150. Axford JS, Howe FA, Heron C, Griffiths JR (2001). Sensitivity of quantitative 1H magnetic resonance spectroscopy of the brain in detecting early neuronal damage in systemic lupus erythematosus. Ann Rheum Dis, 60: 106-111
151. Castellino G, Govoni M, Padovan M, Colamussi P, Borrelli M, Trotta F. (2005). Proton magnetic resonance spectroscopy may predict future brain lesions in SLE patients: a functional multi-imaging approach and follow up. Ann Rheum Dis, 64: 1022-1027
152. Skevington SM (1986). Psychological aspects of pain in rheumatoid arthritis: a review. Soc Sci Med, 23: 567-575
153. Van der Bijl AE, Emmer BJ, Breedveld FC, Middelkoop HA, Jurgens CK, van Buchem MA, et al. (2007). Advanced magnetic resonance imaging of the brain in patients treated with TNF-α blocking agents. Clin Exp Rheumatol, 25: 301-304.
154. Mcgeer PL, Schulzer M, Mcgeer EG. (1996). Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology, 47: 425-432
155. Lleo A, Galea E and Sastre M (2007). Molecular targets of non-steroidal anti-inflammatory drugs in neurodegenerative diseases. Cell Mol Life Sci, 64: 1403-1418
156. Klegeris A and McGeer PL (2005). Non-steroidal anti-inflammatory drugs (NSAIDs) and other anti-inflammatory agents in the treatment of neurodegenerative disease. Curr Alzheimer Res, 2: 355-365
157. Harrison NA, Brydon L, Walker C, Gray MA, Steptoe A and Critchley HD (2009). Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity. Biol Psychiatry, 66: 407-414
158. Brydon L, Harrison NA, Walker C, Steptoe A and Critchley HD (2008). Peripheral inflammation is associated with altered substantia nigra activity and psychomotor slowing in humans. Biol Psychiatry, 63: 1022-1029
159. Wright CE, Strike PC, Brydon L, Steptoe A. (2005). Acute inflammation and negative mood: mediation by cytokine activation. Brain Behav Immun., 19: 345-350
160. Belanger M, Allaman I and Magistretti PJ (2011). Differential effects of pro- and anti-inflammatory cytokines alone or in combinations on the metabolic profile of astrocytes. J Neurochem, 116: 564-576
161. Hess A, Axmann R, Rech J, Finzel S, Heindl C, Kreitz S, Sergeeva M, Saake M, Garcia M, Kollias G, Straub RH, Sporns O, Doerfler A, Brune K and Schett G (2011). Blockade of TNF-alpha rapidly inhibits pain responses in the central nervous system. Proc Natl Acad Sci U S A, 108: 3731-3736
162. Eijsbouts AM, Kempers, M. J.,van den Hoogen, F. H.,Laan, R. F.,Hermus, A. R.,Ross, H. A.,Sweep, F. C.,van de Putte, L. B. (2011). Effects of naproxen and sulphasalazine or methotrexate on hypothalamic-pituitary-adrenal axis activity in patients with rheumatoid arthritis. Clin Exp Rheumatol, 29: 35-42
163. Licastro F, Pedrini, S., Caputo, L., Annoni, G., Davis, L. J., Ferri, C., Casadei, V., & Grimaldi, L.M. (2000). Increased plasma levels of interleukin-1, interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain?. Journal of Neuroimmunology, 103 97-102
164. O'Connor MF and Irwin MR (2010). Links between behavioral factors and inflammation. Clin Pharmacol Ther, 87: 479-482
165. Beavers KM, Brinkley TE and Nicklas BJ (2010). Effect of exercise training on chronic inflammation. Clin Chim Acta, 411: 785-793
166. Warnberg J, Cunningham K, Romeo J and Marcos A (2010). Physical activity, exercise and low-grade systemic inflammation. Proc Nutr Soc, 69: 400-406
167. Teixeira-Lemos E, Nunes S, Teixeira F and Reis F (2011). Regular physical exercise training assists in preventing type 2 diabetes development: focus on its antioxidant and anti-inflammatory properties. Cardiovasc Diabetol, 10: 12
168. Walsh NP, Gleeson M, Shephard RJ, Woods JA, Bishop NC, Fleshner M, Green C, Pedersen BK, Hoffman-Goetz L, Rogers CJ, Northoff H, Abbasi A and Simon P (2011). Position statement. Part one: Immune function and exercise. Exerc Immunol Rev, 17: 6-63
169. Packer N, Pervaiz N and Hoffman-Goetz L (2010). Does exercise protect from cognitive decline by altering brain cytokine and apoptotic protein levels? A systematic review of the literature. Exerc Immunol Rev, 16: 138-162
170. Corsonello A, Garasto S, Abbatecola AM, Rose G, Passarino G, Mazzei B, Pranno L, Guffanti EE, Bustacchini S and Lattanzio F (2010). Targeting inflammation to slow or delay functional decline: where are we? Biogerontology, 11: 603-614
171. Voss MW, Prakash RS, Erickson KI, Basak C, Chaddock L, Kim JS, Alves H, Heo S, Szabo AN, White SM, Wojcicki TR, Mailey EL, Gothe N, Olson EA, McAuley E and Kramer AF (2010). Plasticity of brain networks in a randomized intervention trial of exercise training in older adults. Front Aging Neurosci, 2
172. Kramer AF and Erickson KI (2007). Capitalizing on cortical plasticity: influence of physical activity on cognition and brain function. Trends Cogn Sci, 11: 342-348
173. Erickson KI, Raji CA, Lopez OL, Becker JT, Rosano C, Newman AB, Gach HM, Thompson PM, Ho AJ and Kuller LH (2010). Physical activity predicts gray matter volume in late adulthood: the Cardiovascular Health Study. Neurology, 75: 1415-1422
174. Erickson KI, Voss MW, Prakash RS, Basak C, Szabo A, Chaddock L, Kim JS, Heo S, Alves H, White SM, Wojcicki TR, Mailey E, Vieira VJ, Martin SA, Pence BD, Woods JA, McAuley E and Kramer AF (2011). Exercise training increases size of hippocampus and improves memory. Proc Natl Acad Sci U S A, 108: 3017-3022
175. Gates NJ, Valenzuela M, Sachdev PS, Singh NA, Baune BT, Brodaty H, Suo C, Jain N, Wilson GC, Wang Y, Baker MK, Williamson D, Foroughi N, Fiatarone Singh MA. (2011). Study of Mental Activity and Regular Training (SMART) in at risk individuals: A randomised double blind, sham controlled, longitudinal trial. BMC Geriatr., 11 19
176. Espeland MA, Gill TM, Guralnik J, Miller ME, Fielding R, Newman AB, Pahor M Lifestyle Interventions and Independence for Elders Study Group. (2007). Designing clinical trials of interventions for mobility disability: results from the lifestyle interventions and independence for elders pilot (LIFE-P) trial. J Gerontol A Biol Sci Med Sci, 62: 1237-1243
177. Soreca I, Rosano C, Jennings JR, Sheu LK, Kuller LH, Matthews KA, Aizenstein HJ and Gianaros PJ (2009). Gain in adiposity across 15 years is associated with reduced gray matter volume in healthy women. Psychosom Med, 71: 485-490
178. van de Sande-Lee S, Pereira FR, Cintra DE, Fernandes PT, Cardoso AR, Garlipp CR, Chaim EA, Pareja JC, Geloneze B, Li LM, Cendes F, Velloso LA. (2011). Partial Reversibility of Hypothalamic Dysfunction and Changes in Brain Activity After Body Mass Reduction in Obese Subjects. Diabetes, ePub ahead of print
179. Jang S and Johnson RW (2010). Can consuming flavonoids restore old microglia to their youthful state? Nutr Rev, 68: 719-728
180. Arterburn LM, Hall EB and Oken H (2006). Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am J Clin Nutr, 83: 1467S-1476S
181. O'Brien JS, Fillerup DL and Mead JF (1964). Quantification and fatty acid and fatty aldehyde composition of ethanolamine, choline, and serine glycerophosphatides in human cerebral grey and white matter. J Lipid Res, 5: 329-338
182. Jia Z, Pei Z, Maiguel D, Toomer CJ and Watkins PA (2007). The fatty acid transport protein (FATP) family: very long chain acyl-CoA synthetases or solute carriers? J Mol Neurosci, 33: 25-31
183. Rapoport SI, Purdon D, Shetty HU, Grange E, Smith Q, Jones C and Chang MC (1997). In vivo imaging of fatty acid incorporation into brain to examine signal transduction and neuroplasticity involving phospholipids. Ann N Y Acad Sci, 820: 56-73; discussion 73-54
184. Tassoni D, Kaur G, Weisinger RS and Sinclair AJ (2008). The role of eicosanoids in the brain. Asia Pac J Clin Nutr, 17 Suppl 1: 220-228
185. Kiecolt-Glaser JK (2010). Stress, food, and inflammation: psychoneuroimmunology and nutrition at the cutting edge. Psychosom Med, 72: 365-369
186. Ahmad A, Moriguchi T and Salem N (2002). Decrease in neuron size in docosahexaenoic acid-deficient brain. Pediatr Neurol, 26: 210-218
187. Wainwright PE, Bulman-Fleming, M.B., Levesque, S., Mustsaers, L., Mucheon, D. (1998). A saturated fat diet during development alters dendritic growth in mouse brain.. Nutr Neurosci, 1 49-58
188. Sakamoto T, Cansev M and Wurtman RJ (2007). Oral supplementation with docosahexaenoic acid and uridine-5'-monophosphate increases dendritic spine density in adult gerbil hippocampus. Brain Res, 1182: 50-59
189. Wurtman RJ, Ulus IH, Cansev M, Watkins CJ, Wang L and Marzloff G (2006). Synaptic proteins and phospholipids are increased in gerbil brain by administering uridine plus docosahexaenoic acid orally. Brain Res, 1088: 83-92
190. Boudrault C, Bazinet RP and Ma DW (2009). Experimental models and mechanisms underlying the protective effects of n-3 polyunsaturated fatty acids in Alzheimer's disease. J Nutr Biochem, 20: 1-10
191. Moriguchi T, Greiner RS and Salem N, Jr. (2000). Behavioral deficits associated with dietary induction of decreased brain docosahexaenoic acid concentration. J Neurochem, 75: 2563-2573
192. Rao JS, Ertley RN, Lee HJ, DeMar JC, Jr., Arnold JT, Rapoport SI and Bazinet RP (2007). n-3 polyunsaturated fatty acid deprivation in rats decreases frontal cortex BDNF via a p38 MAPK-dependent mechanism. Mol Psychiatry, 12: 36-46
193. Conklin SM, Gianaros PJ, Brown SM, Yao JK, Hariri AR, Manuck SB and Muldoon MF (2007). Long-chain omega-3 fatty acid intake is associated positively with corticolimbic gray matter volume in healthy adults. Neurosci Lett, 421: 209-212
194. Freund-Levi Y, Hjorth E, Lindberg C, Cederholm T, Faxen-Irving G, Vedin I, Palmblad J, Wahlund LO, Schultzberg M, Basun H and Eriksdotter Jonhagen M (2009). Effects of omega-3 fatty acids on inflammatory markers in cerebrospinal fluid and plasma in Alzheimer's disease: the OmegAD study. Dement Geriatr Cogn Disord, 27: 481-490
195. Harris W (2008). Omega-3 Fatty Acids: The Japanese Factor? J Am Coll Cardiol, 52: 425-427
196. Csuka E, Morganti-Kossmann MC, Lenzlinger PM, Joller H, Trentz O and Kossmann T (1999). IL-10 levels in cerebrospinal fluid and serum of patients with severe traumatic brain injury: relationship to IL-6, TNF-alpha, TGF-beta1 and blood-brain barrier function. J Neuroimmunol, 101: 211-221
197. Sun YX, Minthon L, Wallmark A, Warkentin S, Blennow K and Janciauskiene S (2003). Inflammatory markers in matched plasma and cerebrospinal fluid from patients with Alzheimer's disease. Dement Geriatr Cogn Disord, 16: 136-144
198. Ayala A, Wang P, Ba ZF, Perrin MM, Ertel W, Chaudry IH. (1991). Differential alterations in plasma IL-6 and TNF levels after trauma and hemorrhage. Am J Physiol, 260: R167-171
199. Maier B, Laurer HL, Rose S, Buurman WA and Marzi I (2005). Physiological levels of pro- and anti-inflammatory mediators in cerebrospinal fluid and plasma: a normative study. J Neurotrauma, 22: 822-835